A detailed history of Brown Brothers Harriman & CO transactions in Vericel Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 1,025 shares of VCEL stock, worth $60,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,025
Previous 910 12.64%
Holding current value
$60,218
Previous $41,000 4.88%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.25 - $53.56 $4,858 - $6,159
115 Added 12.64%
1,025 $43,000
Q2 2022

Aug 11, 2022

BUY
$22.88 - $39.45 $20,820 - $35,899
910 New
910 $23,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.77B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.